Q Ma, H Wu, Y Xiao, Z Liang… - … journal of oncology, 2020 - spandidos-publications.com
Pancreatic stellate cells (PSCs) are typically activated in pancreatic ductal adenocarcinoma (PDAC) and release exosomes containing high levels of microRNA‑21 (miR‑21). However …
CC Chang, CC Lin, CH Wang… - Oncology …, 2018 - spandidos-publications.com
Colorectal cancer (CRC) ranks as the third‑leading cause of cancer‑associated mortalities in Taiwan. The expression of ribonucleotide reductase M2 (RRM2) and p53R2 is associated …
G Girolimetti, F Guerra, L Iommarini… - Human Molecular …, 2017 - academic.oup.com
Abstract Development of chemoresistance is a cogent clinical issue in oncology, whereby combination of anticancer drugs is usually preferred also to enhance efficacy. Paclitaxel …
M Zhang, Y Zhao, Q Liu - Apmis, 2017 - Wiley Online Library
Previous studies have reported the relationship between tumor necrosis factor‐α (TNF‐α)− 308G/A and− 238G/A polymorphisms and sepsis risk with inconsistent results. The aim of …
S Sahay, P Tiwari, M Pandey… - Journal of Environmental …, 2019 - dl.begellhouse.com
The risk of cancer development in offspring due to carcinogen exposure during pregnancy is a serious issue. In this study, we explored the involvement of the phosphatidylinositol 3 …
Cancer is a disease that disrupts the body's genetic composition, causing instability in the genome. Moreover, despite notable progress in cancer treatment, the enduring global …
C Pandey, P Tiwari - Journal of Environmental Pathology, Toxicology … - dl.begellhouse.com
MicroRNAs are short non-coding RNAs that inhibit gene expression at the post- transcriptional level. Abnormal microRNA expression has been associated with different …
S Sahay, D Trehan, R Kumari, J Sharma… - Journal of … - dl.begellhouse.com
Bladder cancer (BCa) is approximately 4th most prevalent diagnosed cancer in men and is three times less common in women. Therefore, identifying biomarkers, developing more …